Cisplatin Liposomal

A synthetic formulation in which the antineoplastic agent cisplatin is encapsulated in lipids. Cisplatin liposomal consists of small aggregates of cisplatin covered by a single lipid bilayer. Encasement in liposomes improves cisplatin's tumor bioavailability and toxicity profile. Liposomal encapsulation does not affect the pharmacological properties of cisplatin directly. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition. (NCI Thesaurus)

YOU MAY ALSO LIKE

Cisplatin

A drug used to treat malignant mesothelioma, non-small cell lung cancer, squamous cell carcinoma of the head and neck, and cancers of…

CISNET

A group of researchers supported by the National Cancer Institute (NCI) who use statistical models to help understand how cancer prevention, screening,…

CISH wt Allele

Human CISH wild-type allele is located in the vicinity of 3p21.3 and is approximately 5 kb in length. This allele, which encodes…

CISH Gene

This gene plays a role in cellular signaling.

CISD1 wt Allele

Human CISD1 wild-type allele is located in the vicinity of 10q21.1 and is approximately 21 kb in length. This allele, which encodes…

CISD1 Gene

This gene is involved in both iron-sulfur cluster binding and electron transport.